References
- Desnick, R. J., Ioannou, Y. A., Ioannon, C. M., Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Kinzler, K. E. and Vogelstein, B. : The Metabolic and Molecular Bases of Inherited Disease. MeGraw-Hill, New York 3733-3774 (2001).
- Desnick, R. J. and Brady, R. O. : Fabry disease in childhood. J. Pediatr. 144, S20 (2004). https://doi.org/10.1016/j.jpeds.2004.01.051
- Whitfield, P. D., Calvin, J., Hogg, S., O'Driscoll, E., Halsall, D., Burling, K., Maguire, G., Wright, N., Cox, T. M., Meikle, P. J. and Deegan, P. B. : Monitoring enzyme replacement therapy in Fabry disease-role of urine globotriaosylceramide. J. Inherit. Metab. Dis. 28, 21 (2005). https://doi.org/10.1007/s10545-005-4415-x
- Boscaro, F., Pieraccini, G., la, Marca, G., Bartolucci, G., Luceri, C., Luceri, F. and Oneti, G. : Rapid quantitation of globotriaosylceramide in human plasma and urine a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease. Rapid Commun Mass Spectrom. 16, 1507 (2002). https://doi.org/10.1002/rcm.728
- Chien, Y. H., Olivova, P., Zhang, X. K., Chiang, S. C., Lee, N. C., Keutzer, J. and Hwu, W. L. : Elevation of urinary globotriaosylceramide (GL3) in infants with Fabry disease. Mol. Genet. Metab. 102, 57 (2011). https://doi.org/10.1016/j.ymgme.2010.08.023
- Nelson, B. C., Roddy, T., Araghi, S., Wilkens, D., Thomas, J. J., Zhang, K., Sung, C. C. and Richards, S. M. : Globotriaosylceramide isoform profiles in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 5, 805, 127 (2004).
- Mills, K., Morris, P., Lee, P., Vellodi, A., Waldek, S., Young, E. and Winchester, B. : Measurement of urinary CDH and CTH by tandem mass spectrometry in patientshemizygous and heterozygous for Fabry disease. J. Inherit. Metab. Dis. 28, 35 (2005). https://doi.org/10.1007/s10545-005-5263-4
- Boscaro, F., Pieraccini, G., la, Marca, G., Bartolucci, G., Luceri, C., Luceri, F. and Oneti, G. : Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease. Rapid Commun Mass Spectrom. 16, 1507 (2002). https://doi.org/10.1002/rcm.728
- Mills, K. and Johnson, A. : Winchester Synthesis of novel internal standards for the quantitative determination of plasma ceramide trihexoside in Fabry disease by tandem mass spectrometry. B. FEBS Lett. 515, 171 (2002). https://doi.org/10.1016/S0014-5793(02)02491-2
- Eng, C. M., Guffon, N., Wilcox, W. R., Germain, D. P., Lee, P., Waldek, S., Caplan, L., Linthorst, G. E. and Desnick, R. J. : International collaborative fabry disease study group. N. Engl. J. Med. 45, 9 (2001).
- Nakanishi, T., Funahashi, S., Funai, T., Hashimoto, T. and Shimizu, A. : Chemical diagnosis of Fabry's disease by fluorometric assay and fast atombombardment/mass spectrometry. Ann. Clin. Biochem. 28, 368 (1991). https://doi.org/10.1177/000456329102800410
- Caudron, E., Moliere, D., Zhou, J. Y., Prognon, P. and Germain, D. P. : Recent advances of Fabry disease screening for at risk population. Med. Sci. (Paris) 21, 480 (2005).
- Tanaka, M., Ohashi, T., Kobayashi, M., Eto, Y., Miyamura, N., Nishida, K., Araki, E., Itoh, K., Matsushita, K., Hara, M., Kuwahara, K., Nakano, T. and Yasumoto, N. : Nonoguchi H,Tomita K.Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin. Nephrol. 64, 281 (2005). https://doi.org/10.5414/CNP64281
- Hoffmann, B., Georg, Koch, H., Schweitzer-Krantz, S., Wendel, U. and Mayatepek, E. : Deficient alpha-galactosidase A activity in plasma but no Fabry disease-a pitfall in diagnosis. Clin. Chem. Lab. Med. 43, 1276 (2005).
- Zeidner, K. M., Desnick, R. J. and Ioannou, Y. A. : Quantitative determination of globotriaosylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit. Anal. Biochem. 267, 104 (1999). https://doi.org/10.1006/abio.1998.2966
- Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., Cardarelli, C. O., Sugimoto, Y., Pastan, I., Gottesman, M. M., Brady, R. O. and Kulkarni, A. B. : alpha- Galactosidase A deficient mice: a model of Fabry disease. Proc. Natl. Acad. Sci. USA 94, 2540 (1997). https://doi.org/10.1073/pnas.94.6.2540
- Hoffmann, B. and Mayatepek, E. : Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities. Neuropediatrics 36, 285 (2005). https://doi.org/10.1055/s-2005-872810
- Ichinose, M., Nakayama, M., Ohashi, T., Utsunomiya, Y., Kobayashi, M. and Eto, Y. : Significance of screening for Fabry disease among male dialysis patients. Clin. Exp. Nephrol. 9, 228 (2005). https://doi.org/10.1007/s10157-005-0369-4
- Bierer, G., Kamangar, N., Balfe, D., Wilcox, W. R. and Mosenifar, Z. : Cardiopulmonary exercise testing in fabry disease. Respiration 72, 504 (2005). https://doi.org/10.1159/000087675
- Linthorst, G. E., Hollak, C. E., Korevaar, J. C., Van Manen, J. G., Aerts, J. M. and Boeschoten, E. W. : Alpha-Galactosidase A deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease. Nephrol. Dial. Transplant. 18, 1581 (2003). https://doi.org/10.1093/ndt/gfg194
- Bekri, S., Enica, A., Ghafari, T., Plaza, G., Champenois, I., Choukroun, G., Unwin, R. and Jaeger, P. : Fabry disease in patients with end-stage renal failure: the potential benefits of screening. Nephron. Clin. Pract. 101, c33 (2005). https://doi.org/10.1159/000085709
- Ichinose, M., Nakayama, M., Ohashi, T., Utsunomiya, Y., Kobayashi, M. and Eto, Y. : Significance of screening for Fabry disease among male dialysis patients. Clin. Exp. Nephrol. 9, 228 (2005). https://doi.org/10.1007/s10157-005-0369-4
- Lee, J. K., Kim, G. H., Kim, J. S., Kim, K. K., Lee, M. C. and Yoo, H. W. : Identification of four novel mutations in five unrelated Korean families with Fabry disease. Clin. Genet. 58, 228 (2000).
- Kitagawa, T., Ishige, N., Suzuki, K., Owada, M., Ohashi, T., Kobayashi, M., Eto, Y., Tanaka, A., Mills, K., Winchester, B. and Keutzer, J. : Non-invasive screening method for Fabry disease by measuring globotriaosylceramide in whole urine samples using tandem mass spectrometry. Mol. Genet. Metab. 85, 196 (2005). https://doi.org/10.1016/j.ymgme.2005.01.007
- Rozenfeld, P. A., Tarabuso, A., Ebner, R., Ramallo, G. and Fossati, C. A. : A successful approach for the detection of Fabry patients in Argentina. Clin. Genet. 69, 344 (2006). https://doi.org/10.1111/j.1399-0004.2006.00594.x
- Hasegawa, H., Takano, H., Shindo, S., Takeda, S., Funabashi, N., Nakagawa, K., Toyozaki, T., Kuwabara, Y. and Komuro, I. : Images in cardiovascular medicine. Transition from left ventricular hypertrophy to massive fibrosis in the cardiac variant of Fabry disease. Circulation. 113, e720 (2006). https://doi.org/10.1161/CIRCULATIONAHA.105.584292
- Liu, H. J., Cao, K. J., Li, C. R., Dai, J., Ma, J. Z., Yong, Y. H. and Sun, W. : Alpha-galactosidase A gene mutation in a Chinese family with Fabry disease mimicking clinical features of hypertrophic cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi. 34, 143 (2006).
- Lindsay, A. C., Behar, J. M. and McEwan, J. : Images in cardiology. Fabry's disease, an X-linked recessive condition, can have isolated cardiac manifestations in heterozygote females. Heart. 92, 685 (2006). https://doi.org/10.1136/hrt.2005.075085
- Hagege, A. A., Caudron, E., Damy, T., Roudaut, R., Millaire, A., Etchecopar-Chevreuil, C., Tran, T. C., Jabbour, F., Boucly, C., Prognon, P., Charron, P. and Germain, D. P. : Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test : the FOCUS study. Heart. 97, 131 (2011). https://doi.org/10.1136/hrt.2010.200188
- Yoon, H.-R., Cho, K., Kang, S., Kwon, Y. J., Jeong, C. S. and Lee, Y. S. : Method development for the profiling analysis of urine globotriaosylceramide (Gb-3) for the screening of Fabry disease by tandem mass spectrometry. Yakhak Hoej 51, 96 (2007).
- Choi, J. H., Cho, Y. M., Suh, K. S., Yoon, H. R., Kim, G. H., Kim, S. S., Ko, J. M., Lee, J. H., Park, Y. S. and Yoo, H. W. : Short-term efficacy of enzyme replacement therapy in Korean patients with Fabry disease. J. Korean Med. Sci. 23, 243 (2008). https://doi.org/10.3346/jkms.2008.23.2.243